Michael Ihnat to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Michael Ihnat has written about Drug Evaluation, Preclinical.
Connection Strength
0.014
-
Antiangiogenic and antitumor agents. Design, synthesis, and evaluation of novel 2-amino-4-(3-bromoanilino)-6-benzylsubstituted pyrrolo[2,3-d]pyrimidines as inhibitors of receptor tyrosine kinases. Bioorg Med Chem. 2003 Nov 17; 11(23):5155-70.
Score: 0.014